KLK3 and prostate carcinoma: Although 68Ga-PSMA PET/CT is a technique that has only recentlybeen applied in clinical settings, despite its high cost,68Ga-PSMA PET/CT shows great promise as a tool in the clinicalmanagement of patients with kidney and prostate cancer, especially in thosewith prostate cancer whose PSA levels are elevated even after treatment.